Clinical trials
Brain Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 10 |
| 2023 | 4 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 11 |
| Recruiting | 10 |
| Unknown status | 6 |
| Not yet recruiting | 5 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 8 |
| AbbVie | 4 |
| AstraZeneca | 3 |
| University Hospital, Clermont-Ferrand | 3 |
| Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 3 |
| MapLight Therapeutics | 2 |
| REGEnLIFE SAS | 2 |
| Slb Pharma | 2 |
| TauRx Therapeutics Ltd | 2 |
| University Hospital, Bordeaux | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Diseases | 61 |
| Central Nervous System Diseases | 27 |
| Nervous System Diseases | 26 |
| Neurodegenerative Diseases | 17 |
| Alzheimer Disease | 15 |
| Dementia | 15 |
| Mental Disorders | 13 |
| Neurocognitive Disorders | 11 |
| Tauopathies | 9 |
| Cerebrovascular Disorders | 7 |
Trials
Showing 26 to 50 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.